UBS Group AG Files 6-K Report

TL;DR

UBS Group AG filed its Q3 2025 6-K, check for updates.

AI Summary

UBS Group AG filed a Form 6-K on October 1, 2025, reporting information as of September 30, 2025. The filing includes details for both UBS Group AG (Central Index Key: 0001610520) and UBS AG (Central Index Key: 0001114446), both based in Zurich, Switzerland. This report is filed under the 1934 Securities Exchange Act.

Why It Matters

This filing provides updated information for investors and regulatory bodies regarding UBS Group AG's status as of the end of the third quarter of 2025.

Risk Assessment

Risk Level: low — This is a routine filing providing updated corporate information and does not contain significant new financial or operational disclosures that would inherently increase risk.

Key Numbers

• 20250930 — Report Date (The filing reports information as of this date.)
• 20251001 — Filing Date (The date the report was submitted to the SEC.)

Key Players & Entities

• UBS Group AG (company) — Registrant
• UBS AG (company) — Registrant
• 0001610520 (company) — Central Index Key for UBS Group AG
• 0001114446 (company) — Central Index Key for UBS AG
• Bahnhofstrasse 45, 8001 Zurich, Switzerland (company) — Principal executive office address

FAQ

Filing Documents

• tbtfpresotext6k202510.htm (6-K) — 197KB
• 0001610520-25-000099.txt ( ) — 199KB

business

business in the US. And these have proven to be resilient, even in times of financial stress. Moreover, our fundamentally different business model in contrast to Credit Suisse makes similar write-downs of our DTAs highly unlikely. Slide 9 – PVA measures should not be based on business combination accounting Finally, turning to slide 9 on PVAs. Prudential valuation adjustments reflect an uncertainty overlay in a bank's capital relating to difficult-to-value securities and derivatives. The Federal Council justifies stricter treatment of PVAs by referencing the extensive security position write-downs on Credit Suisse's balance sheet at the close of the acquisition. We believe this argumentation is incorrect. The write downs reflected purchase price allocation adjustments that UBS considered appropriate as part of standard acquisition accounting. PVAs are designed to account for valuation uncertainty in ongoing business operations and should therefore be viewed in the context of our Level 3 asset profile. Today, our holdings amount to only one-tenth of what Credit Suisse and UBS reported on a pro-forma basis in 2007. Since 2Q23, through the run-down of our Non-core and Legacy portfolio we have further reduced Level 3 assets by around 60% to 16 billion, which is less than 1% of our total balance sheet. The proposed PVA measures do not reflect the progress UBS has made in substantially reducing the valuation uncertainty on its balance sheet. Finally, a brief word on AT1. AT1 instruments play an essential role in a crisis. The fact that UBS was able to restart AT1 issuances with strong demand soon after the rescue of Credit Suisse is evidence of investor confidence in these instruments, including importantly under the current Swiss regime and notwithstanding Credit Suisse events. We support steps to further strengthen AT1 instruments as an effective recovery tool, provided

View Full Filing

View this 6-K filing on SEC EDGAR